Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Montebello Diagnostics AS
AS
Active
Org 994171127
3. Etg Ole Deviks Vei 16A, 0666
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2009 · 17 years old
8 employees
www.montebello.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Montebello Diagnostics AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
346M
260M
173M
87M
0M
2021: 278M
278M
2021
2022: 176M (-37% vs 2021)
176M
-37%
2022
2023: 146M (-17% vs 2022)
146M
-17%
2023
2024: 232M (+59% vs 2023)
232M
+59%
2024
2025: 230M (-1% vs 2024)
230M
-1%
2025
EBITDA
NOK millions
96M
72M
48M
24M
0M
2021: 77M
77M
2021
2022: 36M (-53% vs 2021)
36M
-53%
2022
2023: 13M (-64% vs 2022)
13M
-64%
2023
2024: 40M (+208% vs 2023)
40M
+208%
2024
2025: 40M (0% vs 2024)
40M
0%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
229 851
231 668
146 132
175 997
277 837
Staff expenses
−11 161
−10 434
−8 282
−7 913
−8 605
EBITDA
39 925
39 676
13 001
36 065
76 562
Depreciation & amort.
−838
−1 258
−1 284
−953
−960
EBIT
39 087
38 418
11 717
35 112
75 602
Net financials
80
1 433
−1 199
152
343
Profit before tax
39 167
39 851
10 518
35 264
75 945
Tax
8 669
8 496
2 579
7 799
16 715
Net profit
30 498
31 355
7 939
27 465
59 230
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
109 718
110 576
72 772
70 981
143 029
Equity
34 471
34 473
18 118
20 180
26 415
Long-term debt
0
0
0
0
0
Short-term debt
75 246
76 103
54 653
50 801
116 614
Total debt
75 246
76 103
54 653
50 801
116 614
Financial ratios
5-year trend
EBITDA margin
17,4 %
This company
15,8 %
Market median
This company
Market median
10% above market
2021
2025
Equity ratio
31,4 %
This company
38,2 %
Market median
This company
Market median
18% below market
2021
2025
Return on equity
88,5 %
This company
18,4 %
Market median
This company
Market median
381% above market
2021
2025
Net profit margin
13,3 %
This company
8,1 %
Market median
This company
Market median
64% above market
2021
2025
Asset turnover
2,09×
This company
1,12×
Market median
This company
Market median
87% above market
2021
2025
Debt / equity
2,18×
This company
0,62×
Market median
This company
Market median
252% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Montebello Diagnostics AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
